Takeda Oy
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- PANTOZOL CONTROL gastro-resistant tablet 20 mg
- A03 - Agentes contra padecimientos funcionales del estómago e intestino
- ATROPIN TAKEDA solution for injection 1 mg/1 ml
- LITALGIN solution for injection 500 mg/ml+2 mg/ml
- LITALGIN tablet 500 mg+5 mg
- A05 - Terapia biliar y hepática
- ADURSAL film-coated tablet 150 mg
- A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
- CARBOMIX granules for oral suspension 50 g
- A10 - Antidiabéticos
- GLUBRAVA film-coated tablet 850 mg+15 mg
- INCRESYNC film-coated tablet 30 mg+12.5 mg
- INCRESYNC film-coated tablet 30 mg+25 mg
- INCRESYNC film-coated tablet 45 mg+12.5 mg
- INCRESYNC film-coated tablet 45 mg+25 mg
- TANDEMACT tablet 4 mg+30 mg
- TANDEMACT tablet 4 mg+45 mg
- B02 - Antihemorrágicos
- CAPRILON tablet 500 mg
- C01 - Terapia cardíaca
- ADRENALIN TAKEDA solution for injection 0.01%
- G03 - Hormonas sexuales y moduladores del sistema genital
- PAUSANOL pessary 0.5 mg
- PAUSANOL vaginal cream 0.01%
- J01 - Antibacterianos para uso sistémico
- NITROFUR-C film-coated tablet 75 mg+750 mg
- L01 - Antineoplásicos
- NINLARO capsule, hard 2.3 mg
- NINLARO capsule, hard 3 mg
- NINLARO capsule, hard 4 mg
- L03 - Inmunoestimulantes
- MEPACT powder for solution for infusion 4 mg
- N02 - Analgésicos
- FINREXIN NEO powder for oral solution 350 mg+30 mg+300 mg
- INSTANYL nasal spray, solution 100 µg/dose
- INSTANYL nasal spray, solution 200 µg/dose
- INSTANYL nasal spray, solution 50 µg/dose
- MATRIFEN transdermal patch 100 µg/h
- MATRIFEN transdermal patch 12 µg/h
- MATRIFEN transdermal patch 25 µg/h
- MATRIFEN transdermal patch 50 µg/h
- MATRIFEN transdermal patch 75 µg/h
- MORPHIN TAKEDA solution for injection 100 mg/5 ml
- MORPHIN TAKEDA solution for injection 20 mg/1 ml
- OXANEST solution for injection 10 mg/1 ml
- OXANEST solution for injection 100 mg/10 ml
- PAMOLHOT-C effervescent powder 750 mg+300 mg
- N07 - Otros fármacos activos sobre el sistema nervioso
- GLYCOSTIGMIN solution for injection 2.5 mg/ml+0.5 mg/ml